Showing results (151-160 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|January 18, 2020
Relapsed/refractory primary mediastinal large B-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practicesJitender Takyar, Monika Raut, Rebekah Borse, et al.Expert Review of Hematology|November 23, 2019
Reassessing the role of chemoimmunotherapy in chronic lymphocytic leukemiaYasir Khan, Yung Lyou, Monica El-Masry, et al.Expert Review of Hematology|June 13, 2025
Treatment patterns and blood count control in 10,112 patients with polycythemia veraNaveen Pemmaraju, Jingbo Yu, Anupama Vasudevan, et al.Expert Review of Hematology|July 22, 2025
Hematopoietic cell transplantation for leukocyte adhesion deficiency: prevention of graft-versus-host-diseaseMotoi Yamashita, Takahiro Kamiya, Hirokazu KaneganeExpert Review of Hematology|June 23, 2025
Obecabtagene autoleucel, a novel CD19-directed CAR T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: the future for reducing toxicity and T-cell exhaustion?Jean A Yared, Ariel Fromowitz, Mehmet Kocoglu, et al.Expert Review of Hematology|June 14, 2025
Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?Johnny MahlanguExpert Review of Hematology|October 13, 2025
Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific Advisory Group of Australia (MSAG) to Myeloma AustraliaAngelina Yong, Kate Vandyke, Bradley Augustson, et al.Expert Review of Hematology|October 2, 2025
Novel therapeutics for immune thrombocytopenia: an evolving treatment landscapeKun HuangExpert Review of Hematology|June 28, 2025
Non- MPL-W515K/L mutations in myeloproliferative neoplasms: insights from two case reports and a review of the literatureAne Sofie Tønne Nesse, Hilde Kollsete Gjelberg, Miriam Sandnes, et al.Expert Review of Hematology|July 23, 2025
Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trialsSushmitha Rameshbabu, Hariniska Jayaraman Kannan, Mudit Moondra, et al.Pageof 157